Clinical Trials List
2014-02-01 - 2016-05-31
Phase I
Terminated8
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張端瑩 Division of Hematology & Oncology
- Wei-Wu Chen 無
- SUNG-HSIN KUO Division of Hematology & Oncology
- MING-YANG WANG Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
- Chiun-Sheng Huang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chun-Yu Liu Division of General Surgery
- 邱仁輝 無
- Ta-Chung Chao Division of General Surgery
- Yi-Fang Tsai 無
- 金光亮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蘇勇誠 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- 吳志雄 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yung-Chang Lin Division of General Surgery
- 沈士哲 Division of General Surgery
- Wen-Chi Shen Division of General Surgery
- Chi-Chang Yu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳彥豪 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡志文 無
- Chih-Chiang Hung 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
40 participants
